Arkadios Wealth Advisors Supernus Pharmaceuticals, Inc. Transaction History
Arkadios Wealth Advisors
- $2.49 Billion
- Q1 2025
A detailed history of Arkadios Wealth Advisors transactions in Supernus Pharmaceuticals, Inc. stock. As of the latest transaction made, Arkadios Wealth Advisors holds 16,799 shares of SUPN stock, worth $563,774. This represents 0.02% of its overall portfolio holdings.
Number of Shares
16,799Holding current value
$563,774% of portfolio
0.02%Shares
1 transactions
Others Institutions Holding SUPN
# of Institutions
301Shares Held
60.5MCall Options Held
8.8KPut Options Held
6.3K-
Black Rock Inc. New York, NY10.4MShares$349 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.16MShares$207 Million0.0% of portfolio
-
Armistice Capital, LLC New York, NY5.2MShares$174 Million2.59% of portfolio
-
Dimensional Fund Advisors LP Austin, TX2.9MShares$97.4 Million0.02% of portfolio
-
Macquarie Group LTD Australia, C32.7MShares$90.6 Million0.11% of portfolio
About SUPERNUS PHARMACEUTICALS, INC.
- Ticker SUPN
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 53,495,300
- Market Cap $1.8B
- Description
- Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. Its commercial products are Trokendi XR, an extended release topiramate product indicated for the treatment of epilepsy, as well as for the prop...